Summary
The structural hallmark of retroviral transforming onc genes is a specific RNA sequence that is unrelated to the essential retroviral genes but closely related to certain cellular prototypes termed proto-onc genes. Two types of onc genes have been distinguished. Type I are onc genes which utilize elements of specific sequences only to encode a transforming protein. Type II onc genes are hybrids which utilize essential viral (typically gag) and specific RNA sequences to encode transforming proteins. Comparisons between viral onc genes and cellular proto-onc genes are reviewed in the light of two competing models for proto-onc function: the quantitative model, which holds that viral onc genes and cellular proto-onc genes are functionally the same and that transformation is the result of enhanced dosage of a cellular proto-onc gene; and the qualitative model, which holds that they are different. Structural comparisons between viral onc genes and cellular prototypes have demonstrated extensive sequence homologies in the primary structures of the specific sequences. However, qualitative differences exist in the structure and organization of viral onc genes and cellular prototypes. These include differences in promoters, minor differences in the primary structure of shared sequences, and absolute differences such as in the presence of sequences which are unique to viral onc genes or to corresponding cellular genetic units. For example, type II hybrid onc genes of retroviruses share only their specific but not their gag-related elements with the cell, and cellular proto-onc genes are interrupted by sequences of nonhomology relative to viral onc genes. In addition, proto-onc gene units may include unique cellular coding sequences not shared with viral onc genes. There is circumstantial evidence that some proto-onc genes are potentially oncogenic after activation (quantitative model) or modification (qualitative model). Activated by an adjacently integrated retroviral promotor, the cellular prototype of the onc gene of the avian acute leukemia virus MC29 was proposed to cause lymphoma and activated by ligation with viral promoter sequences two proto-onc DNAs, those of Moloney and Harvey sarcoma viruses, were found to transform mouse 3T3 cell lines. Mutations presumably conferred 3T3 cell-transforming ability to the proto-onc gene of Harvey sarcoma virus that has been isolated from a human bladder carcinoma cell line. In no case has an unaltered proto-onc as yet been shown to be necessary and sufficient for carcinogenesis. Despite this and structural differences between viral onc genes and cellular proto-onc genes, we cannot at present conclusively distinguish between the quantitative and the qualitative models because a genetic and functional definition of most viral onc genes and of all cellular prototypes of viral onc genes are not as yet available.
This work was supported by NIH research Grant no., CA 11426 from the National Cancer Institute
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bishop JM (1981) Enemies within: the genesis of retrovirus oncogenes. Cell 23:5–6
Bishop JM, Courtneidge SA, Levinson AD, Oppermann H, Quintrell N, Sheiness DK, Weiss SR, Varmus HE (1980) The origin and function of avian retrovirus transforming genes. Cold Spring Harbor Symp Quant Biol 44:919–930
Bister K, Duesberg PH (1982) Genetic structure and transforming genes of avian retroviruses: In: Klein G (ed) Advances in viral oncology, vol 1. Raven, New York pp 3–42
Bister K, Nunn M, Moscovici C, Perbal B, Baluda MA, Duesberg PH (1982) E26 and AMV: two acute leukemia viruses with related transformation-specific RNA sequences, but different genetic structures, gene products and oncogenic properties. Proc Natl Acad Sci 79:3677–3681
Cooper GA, Neiman PE (1981) Two distinct candidate transforming genes of lymphoid leukosis virus-induced neoplasms. Nature 292: 857–858
DeFeo D, Gonda MA, Young HA, Chang EH, Lowy DR, Scolnick EM, Ellis RW (1981) Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus. Proc Natl Acad Sci USA 78:3328–3332
Der CJ, Krontiris TG, Cooper GM (1982) Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci USA 79: 3637–3640
Duesberg PH (1980). Transforming genes of retroviruses. Cold Spring Harbor Symp Quant Biol 44: 13–29
Duesberg PH, Bister K, Moscovici C (1980) Genetic structure of avian myeloblastosis virus released from transformed myeloblasts as a defective virus particle. Proc Natl Acad Sci 77:5120–5124
Duesberg PH, Robins T, Lee W-H, Bister K, Garon C, Papas T (1982) On the relationship between the transforming onc genes of avian Rous sarcoma and MC29 viruses and homologous loci of the chicken cell. In: Revoltella R et al. (eds) Expression of differentiated functions in cancer cells. Raven, New York, pp 471–484
Eva A, Robbins KC, Andersen PR, Srinivasan A, Tronick SR, Reddy EP, Ellmore NW, Galen AT, Lautenberger JA, Papas TS, Westin E-H, Wong-Staal F, Gallo RC, Aaronson SA (1982) Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells. Nature 295: 116–119
Frankel AE, Fischinger PJ (1976) Nucleotide sequences in mouse DNA and RNA specific for Moloney sarcoma virus. Proc Natl Acad Sci USA 73:3705–3709
Gross L (1970) Oncogenic, viruses. Pergamon, New York
Graf T, Beug H, Hayman MJ (1980) Target cell specificity of defective avian leukemia viruses: Haematopoietic target cells for a given virus type can be infected but not transformed by strains of a different type. Proc Natl Acad Sci USA 77: 389–393
Hayward WS, Neel BG, Astrin SM (1981). Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature, 290:475–480
Huebner RJ, Todaro GJ (1969). Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci USA 64: 1087–1094
Kettmann R, Deschamps J, Cleuter Y, Couez D, Burny A, Marbaix G (1982). Leukemogenesis by bovine leukemia virus: Proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3′ proximate cellular sequences. Proc Natl Acad Sci USA 79: 2465–2469
Lee W-H (1981) Identificaiton and characterization of the transforming gene of Fujinami sarcoma virus and the seuqence relationship of the src gene of Rous sarcoma viruses and the cellular src locus in chicken. PhD Thesis, University of California, Berkeley
Lee W-H, Bister K, Pawson A, Robins T, Moscovici C, Duesberg PH (1980) Fujinami sarcoma virus: An avian RNA tumor virus with a unique transforming gene. Proc Natl Acad Sci USA 77:2018–2022
Lee W-H, Nunn M, Duesberg PH (1981) Src genes of ten Rous sarcoma virus strains, including two reportedly transduced from the cell, are completely allelic; Putative markers of transduction are not detected. J Virol 39:758–776
Lee W-H, Liu C-P, Duesberg PH (1982) DNA clone of avian Fujinami sarcoma virus temperature-sensitive in maintenance of transformation of mammalian cells. J Virol 44:401–412
Mellon P, Pawson A, Bister K, Martin GS, Duesberg PH (1978) Specific RNA sequences and gene products of MC29 avian acute leukemia virus. Proc Natl Acad Sci USA 75:5874–5878
Moscovici C, Samarut J, Gazzolo L, Moscovici MG (1981) Myeloid and erythroid neoplastic responses to avian defective leukemia viruses in chickens and in quail. Virology 113: 765–768
Oskarsson MK, McClements WL, Blair DS, Maizel JV, Vande Woude GF (1980) Properties of a normal mouse cell DNA sequence (sarc) homologous to the src sequence of Moloney sarcoma virus. Science 207: 1222–1224
Parada LF, Tobin CJ, Shih C, Weinberg RA (1982) Human EJ bladder carcinoma oncogene is a homologue of Harvey Sarcoma Virus ras gene. Nature 297:474–478
Parker RC, Varmus HE, Bishop JM (1981) Cellular homologue (c-src) of the transforming gene of Rous sarcoma virus: Isolation, mapping, and transcriptional analysis of c-src and flanking regions. Proc Natl Acad Sci USA 78:5842–5846
Payne GA, Bishop JM, Varmus HE (1982) Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas. Nature 293:209–214
Rechavi G, Givol D, Canaani E (1982) Activation of a cellular oncogene by DNA rearrangement: Possible involvement of an IS-like element. Nature 300:607–611
Rigby PWI (1982) The oncogenic circle closes. Nature 297: 451–453
Robins T, Bister K, Garon C, Papas T, Duesberg P (1982) Structural relationship between a normal chicken DNA locus and the transforming gene of the avian acute leukemia virus MC29. J Virol 41:635–642
Rushlow KE, Lautenberger JA, Papas TS, Baluda MA, Perbal B, Chirikjian JG, Reddy P (1982) Nucleotide sequence of the transforming gene of avian myeloblastosis virus. Science 216: 1421–1426
Saedler H, Reif HJ, Hu S, Davidson N (1974) IS2, a genetic element for turn-off and turn-on of gene activity in E. coli. Molec Gen Genet 132:265–289
Scolnick EM, Parks WP (1974) Harvey sarcoma virus: A second murine type C sarcoma virus with rat genetic information. J Virol 13: 1211–1219
Shalloway D, Zelenetz AD, Cooper GM (1981) Molecular cloning and characterization of the chicken gene homologous to the transforming gene of Rous sarcoma virus. Cell 24:531–542
Shilo B-Z, Weinberg RA (1981) DNA sequences homologous to vertebrate oncogenes are conserved in Drosophila melanogaster. Proc Natl Acad Sci USA 78: 6789–6792
Spector D, Varmus HE, Bishop JM (1978) Nucleotide sequences related to the transforming gene of avian sarcoma virus are present in the DNA of uninfected vertebrates. Proc Natl Acad Sci 75:4102–4106
Stehelin D, Varmus HE, Bishop JM, Vogt PK (1976) DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260: 170–173
Stehelin D, Saule S, Roussel M, Sergeant A, Lagrou C, Rommens C, Raes MB (1980) Three new types of viral oncogenes in defective avian leukemia viruses: I. Specific nucleotide sequences of cellular origin correlate with specific transformation. Cold Spring Harbor Symp Quant Bioi 44: 1215–1223.
Takeya T, Hanafusa H, Junghans RP, Ju G, Skalka AM (1981) Comparison between the viral transforming gene (src) of recovered avian sarcoma virus and its cellular homolog. Mol Cell Biol 1: 1024–1037
Temin HM (1971) The protovirus hypothesis: Speculations on the significance of RNA directed DNA synthesis for normal development and for carcinogenesis. J Natl Cancer Inst 46:3–7
Todaro GJ, Huebner RJ (1972) The viral oncogene hypothesis: New evidence. Proc Natl Acad Sci USA 69: 1009–1015
Tooze J (1973) The molecular biology of tumour viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
Tsichlis PN, Coffin JM (1980) Role of the C region in relative growth rates of endogenous and exogenous avian oncoviruses. Cold Spring Harbor Symp Quant Biol 44: 1123–1132
Van Beveren CV, van Straaten F, Galleshaw JA, Verma IM (1981) Nucleotide sequence of the genome of a murine sarcoma virus. Cell 27:97–108
Watanabe S, Temin HM (1982) Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5′ long terminal repeat and the start of the gag gene. Proc Natl Acad Sci USA 79:5986–5990
Weinberg R (1982) Use of transfection to analyze genetic information and malignant transformation. Biochimica et Biophysica Acta 651: 25–35
Weiss RA, Teich NM, Varmus H, Coffin JM (1982) The molecular biology of tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
Wong T-E, Lai MM-C, Hu SF, Hirano A, Vogt PK (1982) Class II defective avian sarcoma viruses: comparative analysis of genome structure. Virology 120:453–464
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Duesberg, P., Nunn, M., Biehl, T., Phares, W., Lee, WH. (1983). Viral Oncogenes and Cellular Prototypes. In: Neth, R., Gallo, R.C., Greaves, M.F., Moore, M.A.S., Winkler, K. (eds) Modern Trends in Human Leukemia V. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 28. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68761-7_36
Download citation
DOI: https://doi.org/10.1007/978-3-642-68761-7_36
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-11858-9
Online ISBN: 978-3-642-68761-7
eBook Packages: Springer Book Archive